NCT04771780View on ClinicalTrials.gov

Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

June 27, 2022

Study Completion Date

June 27, 2022

Conditions
Hyperphosphatemia
Interventions
DRUG

KHK7791

oral administration

Trial Locations (1)

Unknown

Medical Corporation Seijinkai Ikeda Hospital, Kanoya

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT04771780 - Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis | Biotech Hunter | Biotech Hunter